Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
LSL Pharma Group Inc ( (TSE:LSL) ) has shared an announcement.
LSL Pharma Group Inc. announced a semi-annual interest payment on its unsecured convertible debentures, with a reduced interest rate following the acquisition of Dermolab Pharma Ltd. This acquisition, which complements LSL Pharma’s existing offerings and generated significant revenue, allows the company to lower the interest rate from 11% to 10%, reflecting positively on its financial strategy and potentially benefiting stakeholders.
More about LSL Pharma Group Inc
LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company specializing in the development, manufacturing, and marketing of high-quality sterile ophthalmic pharmaceuticals, as well as cosmetics, pharmaceuticals, and natural health products in solid, semi-solid, and liquid forms.
YTD Price Performance: -20.24%
Average Trading Volume: 50,036
Technical Sentiment Signal: Buy
Find detailed analytics on LSL stock on TipRanks’ Stock Analysis page.